Determination of the number of blood samples needed for optimal detection of cytomegalovirus viremia in immunocompromised patients using a shell-vial assay-Reference-Cited by-同舟云学术

Determination of the number of blood samples needed for optimal detection of cytomegalovirus viremia in immunocompromised patients using a shell-vial assay

Published:1997-04 Issue:4 Volume:16 Page:318-321
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur. J. Clin. Microbiol. Infect. Dis.

Author:

Reina J.,Blanco I.,Munar M.

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF01695639.pdf

Reference17 articles.

1. Rubin RH: Infection in the renal and liver transplant patient. In: Rubin RH, Young LS (ed): Clinical approach to infection in the compromised host. Plenum Publishing, New York, 1988, p. 557–621.

2. Jacobson MA, Mills J: Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment. Annals of Internal Medicine 1988, 108: 585–594.

3. Van der Bij W, Schrim J, Torensma R, Van Son J, Tegzess AM, The TH: Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. Journal of Clinical Microbiology 1988, 26: 2531–2535.

4. Revello MG, Percivalle E, Zavattoni M, Parea M, Grossi P, Gerna G: Detection of human cytomegalovirus immediate-early antigen in leukocytes as a marker of viremia in immunocompromised patients. Journal of Medical Virology 1989, 29: 88–93.

5. Gerna G, Revello MG, Percivalle E, Morini F: Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. Journal of Clinical Microbiology 1992, 30: 1232–1237.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients;CLIN MICROBIOL REV;2000

2. New Strategies for Prevention and Therapy of Cytomegalovirus Infection and Disease in Solid-Organ Transplant Recipients;Clinical Microbiology Reviews;2000-01